Clintec, an IQVIA company, is an innovative, medium-sized, global Contract Research Organization providing global full and functional service support to the pharmaceutical, biotechnology and medical device industries. We are headquartered in the UK and have grown our clinical research business organically over the past 20 years.
What We Do
We are a global contract clinical research organisation that works with the best clinical experts to deliver a unique mix of technical, operational and scientific expertise in drug development.
Where people’s lives are involved, there’s always more to be done, innovation to be discovered. We turn ideas into reality to meet patients’ needs to bring new medicines to market. We use e-clinical technologies to see the big picture in the smallest detail and provide a customized clinical service ensuring excellence at every stage.
Why Choose Clintec?
At Clintec we believe flexibility is the key to success when working with our clients. We endeavor to meet our clients’ needs by being proactive and have created an environment that fosters this approach with our teams.
Based in over 50 countries, our expertise is vast, yet our approach is simple: we’re focused, flexible and forward-thinking.
FOCUSED:
In clinical research every second counts. We take time to get things right first time. We see the bigger picture even while scrutinizing the smallest of details.
FLEXIBLE:
Every challenge is different, so every solution should be different too. We bring together a customized team for each challenge. We tailor our services to not just meet expectations, but exceed them.
FORWARD THINKING:
We’re leaders, not followers. If there’s a way to make something happen, we’ll find it. ‘Impossible’ isn’t in our vocabulary.
Industry
Pharmaceutical Manufacturing, Laboratories
HQ Location
133 Finnieston Street
Glasgow, Strathclyde G3 8HB, GB
Keywords
Global clinical Insourcing/ResourcingClinical ResearchGlobal Patient RecruitmentClinical Manufacturing and SuppliesTop 5 SponsorsEmerging MarketsOncologyBioPharmaceuticalsPhase I-IVBiotechnology